This joint presentation results from the strategic
agreement signed between the two entities in July,
2011.
MEDIAN Technologies (ALMDT), a leading medical imaging
software solutions developer and a service provider for
image interpretation and management in oncology clinical
trials and clinical routine, announced today it will
demonstrate its Lesion Management Solutions -LMS- clinical
application portfolio together with Canon at ITEM, April
13-15, 2012 in Yokohama, Japan.
This joint presentation results from the strategic
partnership agreement signed between Canon Inc and MEDIAN
Technologies in July, 2011, with three major
objectives:
-
To develop new Computer-Aided Diagnosis/Detection
(CAD) products and services,
-
To make these innovative solutions available to hospitals
and biopharmaceutical companies through a cloud-based
Software as a Service (SaaS) offering,
-
To establish major clinical partnerships in Japan and
Asia in particular to validate new imaging solutions
developed through the partnership.
"We have been working very closely with CANON Inc.
since the signature of our long-term
partnership", said Gerard Milhiet, MEDIAN
Executive Vice President and co-founder."We are
thrilled to support CANON in exploring new opportunities in
the region by leveraging existing LMS applications as well
as upcoming co-developed LMS solutions in the context of
oncology clinical routine and clinical trials, healthcare
IT solutions, and lung cancer screening".
The International Technical Exhibition of Medical Imaging
(ITEM) is an academic exhibition organized as a part of JRC
2012 by the Japan Industries Association of Radiological
Systems (JIRA). This annual exhibition covers a wide range
of medical diagnostic imaging devices with related
appliances.
About LMS (Lesion Management Solutions)
MEDIAN Lesion Management Solutions detect, evaluate and
follow-up lesions identified in computed tomography (CT)
scans. The LMS perform a number of measurements
automatically (such as lesion dimensions, volume and
density); these parameters are used in both routine
clinical practice and during clinical trials to evaluate
patient responses to cancer therapies.
LMS are adaptable and compatible with all CT scanners. They
can be integrated into heterogeneous IT environments and
easily installed on sites with very diverse equipment and
software configurations. MEDIAN LMS are provided as
"Software as A Service"; they are web-based,
fully distributed and available anywhere in the world.
About MEDIAN Technologies
MEDIAN Technologies provides advanced imaging solutions for
diagnosing and monitoring cancer patients in clinical
trials and in routine clinical practice. MEDIAN
collaborates with institutes at the cutting edge of medical
imaging, including the French National Institute for
Computer Science and Control (INRIA), the University of
Chicago, and the Swiss Federal Institute of Technology in
Lausanne, Switzerland (EPFL).
MEDIAN is present in the market through direct and indirect
sales of its LMS solutions and through alliances with
specialist cancer centers in Europe and the USA.
MEDIAN has a strategic partnership with Canon, for the
development of new technologies, and with Quintiles, to
offer integrated imaging services for clinical trials to
customers worldwide.
Based in Sophia Antipolis, France, MEDIAN was founded in
2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and
Arnaud Butzbach. The company has a staff of 40, over half
of whom work in R&D, and has a US-based subsidiary.
Contacts
|
MEDIAN Technologies
|
Press - Alizé RP
|
|
Fredrik Brag, CEO
+33 492 90 65 82
|
Caroline Carmagnol
+33 6 64 18 99 59
+33 1 42 68 86 43
Anne-Sophie Cosquéric
+33 1 42 68 68 41
|
Recommend:
